These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 9086006)
1. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-analysis Group. J Natl Cancer Inst; 1997 Apr; 89(7):497-505. PubMed ID: 9086006 [TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS). James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I; Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287 [TBL] [Abstract][Full Text] [Related]
3. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer. Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328 [TBL] [Abstract][Full Text] [Related]
4. [Comparing the effect of adjuvant chemotherapy by portal vein infusion with intraluminal chemotherapy for colorectal cancer]. Pan ZZ; Wan DS; Lu ZH; Li LR; Chen G; Zhou ZW; Wu XJ; Ding PR; Wang FL Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):918-21. PubMed ID: 15363253 [TBL] [Abstract][Full Text] [Related]
5. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group]. Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A; Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant regional chemotherapy after hepatic resection for colorectal metastases. Ambiru S; Miyazaki M; Ito H; Nakagawa K; Shimizu H; Nakajima N Br J Surg; 1999 Aug; 86(8):1025-31. PubMed ID: 10460638 [TBL] [Abstract][Full Text] [Related]
7. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer. Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D; Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198 [TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer. Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458 [TBL] [Abstract][Full Text] [Related]
9. [Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma]. Bokemeyer C; Hartmann JT; Kanz L Praxis (Bern 1994); 1997 Sep; 86(39):1510-6. PubMed ID: 9411671 [TBL] [Abstract][Full Text] [Related]
10. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer. Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195 [TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer. Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990 [TBL] [Abstract][Full Text] [Related]
12. [Final evaluation of the randomized multicenter study SAKK 40/81: adjuvant portal chemotherapy of curatively resected colorectal cancer]. Laffer U; Metzger U; Aeberhard P; Arigoni M; Arma S; Barras J; Egeli R; Martinoli S; Müller W; Schweizer W Helv Chir Acta; 1992 Mar; 58(5):755-8. PubMed ID: 1592650 [TBL] [Abstract][Full Text] [Related]
13. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases. Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433 [TBL] [Abstract][Full Text] [Related]
14. Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancer. Gerard A; Pector JC; Bleiberg H Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2351-4. PubMed ID: 3137873 [TBL] [Abstract][Full Text] [Related]
15. Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinoma. Price TJ; Ross PJ; Hickish T; Tait D; Norman AR; Ford HE; Middleton G; Sumpter K; Hill M; Oates J; Cunningham D Clin Colorectal Cancer; 2004 Feb; 3(4):235-42. PubMed ID: 15025796 [TBL] [Abstract][Full Text] [Related]
16. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer]. Kodaira S; Shatari T; Nozawa K Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163 [TBL] [Abstract][Full Text] [Related]
17. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial. Sadahiro S; Suzuki T; Ishikawa K; Yasuda S; Tajima T; Makuuchi H; Saitoh T; Murayama C Cancer; 2004 Feb; 100(3):590-7. PubMed ID: 14745877 [TBL] [Abstract][Full Text] [Related]
18. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384 [TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: perioperative regional liver chemotherapy for improving survival and preventing liver metastases in patients with colorectal carcinoma. Tang JT; Wang JL; Fang JY J Dig Dis; 2010 Aug; 11(4):208-14. PubMed ID: 20649733 [TBL] [Abstract][Full Text] [Related]
20. [Status of portal perfusion in colorectal cancer. Swiss Study Group for Clinical Cancer Research]. Metzger U; Laffer U; Egeli R; Arma S; Aeberhard P; Barras JP; Martinoli S; Müller W; Castiglione M; Schroeder R Chirurg; 1994 Jun; 65(6):509-13. PubMed ID: 8088206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]